{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:32:46Z","timestamp":1788877966294,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s40123-025-01171-6","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:28:52Z","timestamp":1748831332000},"page":"1581-1595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Patients with Allergic Conjunctivitis and Tear Film Dysfunction: A Randomized Controlled Trial"],"prefix":"10.1007","volume":"14","author":[{"given":"Mario","family":"Troisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Troisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Strianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"1171_CR1","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.2174\/0113816128275375231030115828","volume":"29","author":"VR Regu","year":"2023","unstructured":"Regu VR, Swain RP, Subudhi BB. Drug delivery for ocular allergy: current formulation design strategies and future perspectives. Curr Pharm Des. 2023;29:2626\u201339.","journal-title":"Curr Pharm Des"},{"key":"1171_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.alit.2022.09.005","volume":"72","author":"K Fukuda","year":"2023","unstructured":"Fukuda K, Kishimoto T, Sumi T, Yamashiro K, Ebihara N. Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye. Allergol Int. 2023;72:234\u201344.","journal-title":"Allergol Int"},{"key":"1171_CR3","doi-asserted-by":"publisher","first-page":"1173683","DOI":"10.3389\/ftox.2023.1173683","volume":"5","author":"S Patel","year":"2023","unstructured":"Patel S, Mittal R, Kumar N, Galor A. The environment and dry eye\u2014manifestations, mechanisms, and more. Front Toxicol. 2023;5:1173683.","journal-title":"Front Toxicol"},{"key":"1171_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11882-024-01150-0","volume":"24","author":"A Leonardi","year":"2024","unstructured":"Leonardi A, Quintieri L, Presa IJ, Lloves JM, Montero J, Ben\u00edtez-Del-Castillo JM, et al. Allergic conjunctivitis management: update on ophthalmic solutions. Curr Allergy Asthma Rep. 2024;24:347\u201360.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1171_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/aos.12985","volume":"94","author":"G Van Setten","year":"2016","unstructured":"Van Setten G, Labetoulle M, Baudoin C, Rolando M. Evidence of seasonality and effects of psychometry in dry eye disease. Acta Ophthalmol. 2016;94:499\u2013506.","journal-title":"Acta Ophthalmol"},{"key":"1171_CR6","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.ophtha.2015.02.013","volume":"122","author":"N Kumar","year":"2015","unstructured":"Kumar N, Feuer W, Lanza NL, Galor A. Seasonal variation in dry eye. Ophthalmology. 2015;122:1727\u20139.","journal-title":"Ophthalmology"},{"key":"1171_CR7","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.2147\/OPTH.S148650","volume":"11","author":"M Ayaki","year":"2017","unstructured":"Ayaki M, Kawashima M, Uchino M, Tsubota K, Negishi K. Possible association between subtypes of dry eye disease and seasonal variation. Clin Ophthalmol. 2017;11:1769\u201375.","journal-title":"Clin Ophthalmol"},{"key":"1171_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15:438\u2013510.","journal-title":"Ocul Surf"},{"key":"1171_CR9","first-page":"1881","volume":"28","author":"S Barabino","year":"2024","unstructured":"Barabino S, Ben\u00edtez-Del-Castillo JM. Dry eye disease pathogenesis and clinical signs: searching for correspondence in clinical practice. Eur Rev Med Pharmacol Sci. 2024;28:1881\u201390.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1171_CR10","first-page":"806","volume":"14","author":"J Garcia-Queiruga","year":"2024","unstructured":"Garcia-Queiruga J, Pena-Verdeal H, Sabucedo-Villamarin B, Garcia-Resua C, Giraldez MJ, Yebra-Pimentel E. Temporal progression of entry factors into the vicious circle of dry eye in untreated sufferers. Life (Basel). 2024;14:806.","journal-title":"Life (Basel)"},{"issue":"24","key":"1171_CR11","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.3390\/jcm13247569","volume":"13","author":"M Troisi","year":"2024","unstructured":"Troisi M, Del Prete S, Troisi S, Del Prete A, Bellucci C, Marasco D, Costagliola C. The role of scanning electron microscopy in the evaluation of conjunctival microvilli as an early biomarker of ocular surface health: a literature review. J Clin Med. 2024;13(24):7569.","journal-title":"J Clin Med"},{"issue":"6","key":"1171_CR12","first-page":"653","volume":"14","author":"M Troisi","year":"2024","unstructured":"Troisi M, Caruso C, D\u2019Andrea L, Rinaldi M, Piscopo R, Troisi S, Costagliola C. Compatibility of a new ocular surface dye with disposable and bi-weekly soft contact lenses: an experimental study. Life (Basel). 2024;14(6):653.","journal-title":"Life (Basel)"},{"issue":"9","key":"1171_CR13","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.3390\/biomedicines12091945","volume":"12","author":"M Troisi","year":"2024","unstructured":"Troisi M, Del Prete S, Troisi S, Marasco D, Rinaldi M, Costagliola C. Scanning electron microscopy (SEM) evaluation of the ultrastructural effects on conjunctival epithelial cells of a new multiple-action artificial tear containing cross-linked hyaluronic acid, cationic liposomes and trehalose. Biomedicines. 2024;12(9):1945.","journal-title":"Biomedicines"},{"key":"1171_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109121","volume":"221","author":"T Su\u00e1rez-Cort\u00e9s","year":"2022","unstructured":"Su\u00e1rez-Cort\u00e9s T, Merino-Inda N, Benitez-Del-Castillo JM. Tear and ocular surface disease biomarkers: a diagnostic and clinical perspective for ocular allergies and dry eye disease. Exp Eye Res. 2022;221: 109121.","journal-title":"Exp Eye Res"},{"key":"1171_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.18176\/jiaci.0963","volume":"33","author":"R Herrero-Vanrell","year":"2023","unstructured":"Herrero-Vanrell R, J\u00e1uregui Presa I, Leceta Bilbao A, Montero-Iruzubieta J. Fundamental aspects and relevance of components in antihistamine eye drops. J Investig Allergol Clin Immunol. 2023;33:431\u20138.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"1171_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/pai.12197","volume":"25","author":"P Vichyanond","year":"2014","unstructured":"Vichyanond P, Pacharn P, Pleyer U, Leonardi A. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes. Pediatr Allergy Immunol. 2014;25:314\u201322.","journal-title":"Pediatr Allergy Immunol"},{"key":"1171_CR17","first-page":"233","volume":"25","author":"F Purello D\u2019Ambrosio","year":"1997","unstructured":"Purello D\u2019Ambrosio F, Gangemi S, Ricciardi L, Cuzzocrea S, Di Lorenzo G. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen. Allergol Immunopathol (Madr). 1997;25:233\u20137.","journal-title":"Allergol Immunopathol (Madr)"},{"key":"1171_CR18","first-page":"328","volume":"26","author":"C Blondin","year":"2003","unstructured":"Blondin C, Cholley B, Haeffner-Cavaillon N, Goldschmidt P. Effets modulateurs de collyres anti-allergiques sur l\u2019activation du compl\u00e9ment induite in vitro par des polluants particulaires [In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter]. J Fr Ophtalmol. 2003;26:328\u201336.","journal-title":"J Fr Ophtalmol"},{"key":"1171_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1398-9995.1990.tb00512.x","volume":"45","author":"PL Goldschmidt","year":"1990","unstructured":"Goldschmidt PL, Vulliez-Le Normand B, Briquet I, Dray F. Effects of N-acetyl-aspartyl glutamic acid and sodium cromoglycate on leukotriene B4 secretion by human leukocytes. Allergy. 1990;45:363\u20139.","journal-title":"Allergy"},{"key":"1171_CR20","first-page":"273","volume":"12","author":"D Jambou","year":"1990","unstructured":"Jambou D, Lapalus P. Effect of  N-acetyl-aspartyl-glutamate (NAAGA) on in-vitro leukotriene synthesis by macrophage cell line P388D1. Int J Tissue React. 1990;12:273\u201380.","journal-title":"Int J Tissue React"},{"key":"1171_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jfo.2009.09.006","volume":"32","author":"F Brignole-Baudouin","year":"2009","unstructured":"Brignole-Baudouin F, Robert PY, Creuzot-Garcher C, Olmiere C, Delval L, Baudouin C. Evaluation de l\u2019efficacit\u00e9 du NAAGA dans la s\u00e9cheresse oculaire [Evaluation of NAAGA efficacy in dry eye syndrome]. J Fr Ophtalmol. 2009;32:613\u201320.","journal-title":"J Fr Ophtalmol"},{"key":"1171_CR22","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1007\/s00417-022-05682-x","volume":"260","author":"D Shin","year":"2022","unstructured":"Shin D, Sang MJ. Comparison of treatment effects between 4.9%  N-acetyl-aspartyl glutamic acid and 0.05% cyclosporine A eye drops in dry eye patients. Graefes Arch Clin Exp Ophthalmol. 2022;260:3285\u201391.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1171_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S0181-5512(08)74741-7","volume":"31","author":"S Lazreg","year":"2008","unstructured":"Lazreg S, Colin J, Renault D, Hartani D. Traitement de la conjonctivite allergique per-annuelle et saisonni\u00e8re: comparaison de deux protocoles th\u00e9rapeutiques [Intra-annual and seasonal allergic conjunctivitis treatment: comparison of two therapeutic protocols]. J Fr Ophtalmol. 2008;31:961\u20137.","journal-title":"J Fr Ophtalmol"},{"key":"1171_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1185\/030079903125001785","volume":"19","author":"IG James","year":"2003","unstructured":"James IG, Campbell LM, Harrison JM, Fell PJ, Ellers-Lenz B, Petzold U. Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhino-conjunctivitis. Curr Med Res Opin. 2003;19:313\u201320.","journal-title":"Curr Med Res Opin"},{"key":"1171_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/ACI.0000000000000773","volume":"21","author":"P Janeczko","year":"2021","unstructured":"Janeczko P, Norris MR, Bielory L. Assessment of receptor affinities of ophthalmic and systemic agents in dry eye disease. Curr Opin Allergy Clin Immunol. 2021;21:480\u20135.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"1171_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/jop.2022.0133","volume":"39","author":"VL Perez","year":"2023","unstructured":"Perez VL, Mah FS, Willcox M, Pflugfelder S. Anti-inflammatories in the treatment of dry eye disease: a review. J Ocul Pharmacol Ther. 2023;39(2):89\u2013101.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"1171_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/ICL.0000000000000729","volume":"47","author":"R Arita","year":"2021","unstructured":"Arita R, Fukuoka S. Efficacy of azithromycin eyedrops for individuals with meibomian gland dysfunction-associated posterior blepharitis. Eye Contact Lens. 2021;47(1):54\u20139.","journal-title":"Eye Contact Lens"},{"key":"1171_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/ijpvm.IJPVM_220_19","volume":"12","author":"A Miroliaei","year":"2021","unstructured":"Miroliaei A, Farahani RH, Taheri M, Hazrati E. Use of azelastine and sodium chloride spray for prevention of sinusitis in ICU-admitted patients: a randomized clinical trial. Int J Prev Med. 2021;12:97.","journal-title":"Int J Prev Med"},{"key":"1171_CR29","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1136\/bjo.2007.117515","volume":"91","author":"A Leonardi","year":"2007","unstructured":"Leonardi A, Bremond-Gignac D, Bortolotti M, Violato D, Pouliquen P, Delval L, et al. Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients. Br J Ophthalmol. 2007;91:1662\u20136.","journal-title":"Br J Ophthalmol"},{"key":"1171_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2024.104169","volume":"47","author":"L El Fekih","year":"2024","unstructured":"El Fekih L, Khairallah M, Ben Amor H, Mahmoud A, Chiambaretta F, Messaoud R. Successful management of dry eye disease with a new eye drop formulation combining hyaluronic acid, trehalose, and  N-acetyl-aspartyl-glutamic acid (NAAGA). J Fr Ophtalmol. 2024;47: 104169.","journal-title":"J Fr Ophtalmol"},{"key":"1171_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2210-5-8","volume":"5","author":"H Liu","year":"2005","unstructured":"Liu H, Farley JM. Effects of first- and second-generation antihistamines on muscarinic-induced mucus gland cell ion transport. BMC Pharmacol. 2005;5:8. https:\/\/doi.org\/10.1186\/1471-2210-5-8.","journal-title":"BMC Pharmacol"},{"key":"1171_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejphar.2004.11.006","volume":"506","author":"RF Orzechowski","year":"2005","unstructured":"Orzechowski RF, Currie DS, Valancius CA. Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models. Eur J Pharmacol. 2005;506:257\u201364. https:\/\/doi.org\/10.1016\/j.ejphar.2004.11.006.","journal-title":"Eur J Pharmacol"},{"key":"1171_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2165\/00003495-200565020-00004","volume":"65","author":"L Bielory","year":"2005","unstructured":"Bielory L, Lien KW, Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs. 2005;65:215\u201328.","journal-title":"Drugs"},{"key":"1171_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/285851","volume":"2012","author":"FT Fraunfelder","year":"2012","unstructured":"Fraunfelder FT, Sciubba JJ, Mathers WD. The role of medications in causing dry eye. J Ophthalmol. 2012;2012: 285851.","journal-title":"J Ophthalmol"},{"key":"1171_CR35","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2147\/OPTH.S13479","volume":"4","author":"PB Williams","year":"2010","unstructured":"Williams PB, Crandall E, Sheppard JD. Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis. Clin Ophthalmol. 2010;4:993\u20131001.","journal-title":"Clin Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01171-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01171-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01171-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T03:49:53Z","timestamp":1749872993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01171-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1171"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01171-6","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mario Troisi, Salvatore Troisi, Diego Strianese, Michele Rinaldi, Maria Vittoria Turco, and Ciro Costagliola declare that they have no competing interests. Patients were not involved in the design of the study or the dissemination of the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Salerno Hospital University Ethics Committee (authorization number 31\/2019) and retrospectively registered at ClinicalTrials.gov (identifier NCT06800274). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. Written informed consent was obtained from all participants prior to inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}